How Buckingham Research Currently Rates Moelis (NYSE:MC)
Buckingham Research issued Neutral rating on Moelis (NYSE:MC). The firm have begun coverage on shares of MC in an analyst note issued to investors and clients on 21 December.
From a total of 9 analysts covering Moelis & Co (NYSE:MC) stock, 0 rate it a ”Buy”, 0 a “Sell”, and 0 a ”Hold”. This means that NaN of the ratings are positive. The highest target price is $39 while the lowest target price is $30. The mean of all analyst targets is $33.44 with a 17.04% above today’s ($28.34) stock price. Moelis & Co was the topic of 10 analyst reports since August 11, 2015 according to the firm StockzIntelligence Inc. Sandler O’Neill initiated shares on November 30 with “Buy” rating. KBW upgraded MC stock in a recent report from August 11 to “Outperform” rating. Finally, Wood upgraded the stock to “Market Perform” rating in a report issued on an August 11.
Approximately 7,069 shares of stock traded hands. Moelis & Co (NYSE:MC) has declined 1.84% since May 18, 2015 and is downtrending. It has outperformed by 3.96% the S&P500.
Moelis & Company is an investment bank that provides strategic and financial advice to a client base, including firms, Governments and financial sponsors. The company has a market cap of $1.47 billion. The Firm assists its clients in achieving their strategic goals by offering financial advisory services across all industry sectors. It has 17.77 P/E ratio. It advices its clients on decisions, including mergers and acquisitions , recapitalizations and restructurings, and other corporate finance matters.
According to Zacks Investment Research, “Moelis & Company is a global independent investment bank. The Company provides innovative strategic advice and solutions to a diverse client base, including corporations, governments and financial sponsors. It advises clients in the areas of mergers and acquisitions, recapitalizations and restructurings, and other corporate finance matters. Moelis & Company is based in New York.”